Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
3,489,804
-
Share change
-
+915,483
-
Total reported value
-
$15,077,283
-
Put/Call ratio
-
1.2%
-
Price per share
-
$4.32
-
Number of holders
-
28
-
Value change
-
+$4,150,479
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2023
As of 30 Jun 2023 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,489,804 shares of stock of the company.
Largest 10 holders included COOPERMAN LEON G, VANGUARD GROUP INC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Bleichroeder LP, EAM Investors, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO. LLC., NORTHERN TRUST CORP, and BlackRock Inc..
This table shows 29 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.